During the past decade, Western Illinois Cancer Treatment Center conducted 174 clinical trials. In the 10-year time frame, 174 clinical trials started and 88 clinical trials were completed, i.e. on average, 50.6% percent of trials that started reached the finish line to date. In the past 5 years, 78 clinical trials started and 64 clinical trials were completed. i.e. 82.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Western Illinois Cancer Treatment Center" #1 sponsor was "National Cancer Institute (NCI)" with 113 trials, followed by "Alliance for Clinical Trials in Oncology" with 39 trials sponsored, "SWOG Cancer Research Network" with 39 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored and "NRG Oncology" with 21 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Western Illinois Cancer Treatment Center" #1 collaborator was "National Cancer Institute (NCI)" with 125 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Western Illinois Cancer Treatment Center" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Recurrent Breast Carcinoma" (9 trials), "Invasive Breast Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Western Illinois Cancer Treatment Center" in a lesser frequency.

Most popular intervention types in "Western Illinois Cancer Treatment Center" are "Drug" (190 trials), "Other" (150 trials), "Biological" (90 trials), "Procedure" (67 trials) and "Radiation" (43 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (72 trials), "Quality-of-Life Assessment" (61 trials), "Questionnaire Administration" (43 trials), "Biospecimen Collection" (34 trials) and "Cisplatin" (34 trials). Other intervention names were less common.

The vast majority of trials in "Western Illinois Cancer Treatment Center" are 199 trials for "All" genders, 37 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Western Illinois Cancer Treatment Center". undefined are not yet recruiting, 73 are recruiting, 105 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Western Illinois Cancer Treatment Center, 8 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Western Illinois Cancer Treatment Center, 13 "Phase 1" clinical trials were conducted, 120 "Phase 2" clinical trials and 119 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".